DTB Podcast – Details, episodes & analysis

In this podcast recorded in early July, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) continue to ignore political and sporting events and talk about the August issue of DTB. They discuss the editorial that highlights the growth in the use of psychotropic medication in children and young people and some of the challenges associated with this trend. They talk about a study that assessed the harms of changing frail older people with AF from warfarin to a DOAC. The main article is an overview of the evidence for fezolinetant for the treatment of menopausal vasomotor symptoms.

 

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page. If you want to contact us please email dtb@bmj.com. Thank you for listening.

In this podcast recorded in early June, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) ignore the UK general election, the T20 cricket world cup and the European football championship and talk about the July 2024 issue of DTB. They discuss the editorial that highlights trial data showing that dupilumab had a modest effect on reducing COPD exacerbations, and question whether more drugs or greater investment in pulmonary rehabilitation and smoking cessation services are a better use of resources. They review a coroner's prevention of future deaths report that highlights the need to raise awareness of the dangers of propranolol overdose. The main article discusses the management of exacerbations of COPD in primary care.  

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page. If you want to contact us please email dtb@bmj.com. Thank you for listening.

 

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the October 2023 issue of DTB. They discuss NHS prescription charges in England and the impact they have on people with long-term ill health (https://dtb.bmj.com/content/61/10/146). They talk about a study that assessed the incidence of retinopathy associated with hydroxychloroquine (https://dtb.bmj.com/content/61/10/148). The main article discusses intravenous vitamins and reviews the evidence for their use for serious medical conditions and the evidence for their use in the absence of a specific vitamin deficiency or medical condition (https://dtb.bmj.com/content/61/10/151).    The latest issue of Australian Prescriber mentioned in thia podcast is available from https://australianprescriber.tg.org.au/.   Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). If you want to contact us please email dtb@bmj.com. Thank you for listening.

Why should we worry about the new European Medicines Agency (EMA) pilot project to accelerate the approval of new drugs? James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the October issue Editorial, that looks at the pros and cons of this new trend both in the USA and Europe. Read the full article here: http://dtb.bmj.com/content/54/10/109.full. Also in this podcast: • the use of the new antibiotic Fosfomycin trometamol for the treatment of acute uncomplicated lower urinary tract infections (UTIs) –http://dtb.bmj.com/content/54/10/114.abstract;

• as well as the "health condition" of point-of-care tests for respiratory tract infections (RTI) in improving diagnosis capabilities in GP surgeries - http://dtb.bmj.com/content/54/10/117.full.

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the use of nalmefene in the management of alcohol dependence. Although the drug has been approved for use in the NHS, DTB's editorial highlights limitations of the evidence supporting its use and discusses concerns raised by three groups of researchers. Currently, the NHS in England spends £20,000 per month on the drug in primary care. Read the full editorial here: http://dtb.bmj.com/content/54/9/97.full. There’s also a review of the management of hidradenitis suppurativa. Article accessible here: http://dtb.bmj.com/content/54/9/102.full.

The DTB editors also talk about the benefits and limitations of observational studies. Article accessible here: http://dtb.bmj.com/content/54/9/105.full.

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the presentation of guidelines and ways of making them more accessible. Read the full editorial here: http://dtb.bmj.com/content/54/8/85.full There’s also an evaluation of the use of capsaicin for diabetic peripheral neuropathy. Article accessible here: http://dtb.bmj.com/content/54/8/90.full

The DTB editors also talk about medicines, excipients and dietary intolerances. Article accessible here: http://dtb.bmj.com/content/54/8/93.full

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss proposals to stop the prescription of some medicines and foods in order to help manage the deficit in NHS budgets. Full article available here: http://dtb.bmj.com/content/early/2016/07/07/dtb.2016.7.0409.full.

The podcast also includes a review of an article about the effects of the antidiabetic drug empagliflozin on cardiovascular outcomes, as well as a review of an article on the use of vitamin supplementation during pregnancy. Read this article here: http://dtb.bmj.com/content/early/2016/07/11/dtb.2016.7.0414.full.

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the use of herbal products. They also develop the highlights of the articles: Articles: "Frailty, polypharmacy and deprescribing" and "Sacubitril valsartan for heart failure" Read all the articles featured here: dtb.bmj.com/content/54/6.toc

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss health checks for young people with learning disabilities and review two recently licensed drugs - one for treating orthostatic hypotension and the other for managing ADHD in children and adolescents.

Read all the articles featured here: dtb.bmj.com/content/54/5.toc

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the Cancer Drug Fund for England; review a new indication for the combination of oxycodone and naloxone for the management of restless legs syndrome; and consider the impact of animal-derived medicines. Read the articles featured here: Editorial: NICE and the cancer drugs fund for England

Articles: 1. Targinact for restless legs syndrome 2. Implications of religious and cultural beliefs on selection of medicines